Gemphire Announces Pricing Of $22 Million Public Offering Of Common Stock
February 08, 2018 at 12:42 PM EST
Gemphire Therapeutics Inc. today announced the pricing of its previously announced underwritten public offering of 3,142,858 shares of its common stock at a public offering price of $7.00 per share.
